Global Epidemiology of Telogen Effluvium After COVID-19 Pandemic: A Systematic Review and Modeling Study

    September 2024 in “ JAAD International ”
    Jae Joon Jeon, You Hyun Kim, HyunJun Kang, Min Chul Ha, Seung‐Won Jung, Hwancheol Son, Myung Ha Kim, Won‐Soo Lee, Solam Lee
    Image of study
    TLDR Telogen effluvium increased globally after COVID-19, especially in Asian and Latin regions.
    This study systematically reviewed and modeled the global epidemiology of telogen effluvium (TE) before and after the COVID-19 pandemic, using data from 90 studies across 26 countries. The global prevalence of TE increased from 3.44% before the pandemic to 5.41% after. The highest prevalence was observed in China (13.33%) and the lowest in the US (2.08%). The study highlighted a significant increase in TE incidence among Hispanic/Latinx and Asian populations during the pandemic, with a generally higher prevalence in Asia and Latin regions. The study suggests that systemic inflammatory responses from COVID-19 may contribute to TE, though the exact mechanism remains unclear. Limitations include a focus on outpatient populations and insufficient data to differentiate acute from chronic TE. The findings underscore the need for further research on TE predisposition related to race and ethnicity, especially given the growing skin-of-color populations in the US.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 424 results

      community FINASTRIDE and switch to DUTASTRIDE, my experience

      in Progress Pictures  139 upvotes 3 months ago
      The user shared their experience with Finasteride and Dutasteride for hair loss. They initially had success with Finasteride but switched to Dutasteride after experiencing shedding, which continued, and are now considering a hair transplant.
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 4 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community I am a dermatologist with a clinical interest in alopecia. AMA

      in Will treatment work for me? 2 years ago
      In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.

      community The Worst Hair Loss Condition You (MAY) have: LPP

      in Research/Science  43 upvotes 3 months ago
      Lichen Planopilaris (LPP) is an autoimmune condition causing permanent hair loss and fibrosis, often misdiagnosed. Treatments include pioglitazone, topical corticosteroids, anti-inflammatory medication, and Jak inhibitors.

    Similar Research

    5 / 1000+ results